Stuart Therapeutics, Inc. Appoints Dave LeCause as Senior Commercial Advisor
-
September 18, 2026
-
2 min
September 18, 2026
Essilor Instruments' eye-light® delivers targeted, condition-specific management for ocular surface diseases
June 2, 2026
Neda Gioia, OD, CNS, FMCP, FOWNS, reviewed how levels of individual hormones and the balance between them help regulate tear production, inflammation, wound healing, lipid secretion, intraocular pressure (IOP), and neuroprotection, and therefore can result in a higher burden of dry eye, glaucoma, or retinal disease in women.
June 17, 2026